Insider Transactions in Q2 2021 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2021
|
Peter Kies CFO |
SELL
Open market or private sale
|
Direct |
33,750
-20.51%
|
$337,500
$10.01 P/Share
|
|
Jun 09
2021
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+7.71%
|
$27,500
$2.16 P/Share
|
|
Jun 09
2021
|
Laurent Humeau Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,318
-11.56%
|
$92,862
$9.07 P/Share
|
|
Jun 09
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
38,535
-64.09%
|
$385,350
$10.01 P/Share
|
|
Jun 03
2021
|
Peter Kies CFO |
SELL
Open market or private sale
|
Direct |
10,000
-6.22%
|
$80,000
$8.03 P/Share
|
|
May 17
2021
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
3,045
-5.05%
|
$18,270
$6.62 P/Share
|
|
May 17
2021
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
3,045
-0.35%
|
$18,270
$6.62 P/Share
|
|
May 17
2021
|
Lota S. Zoth Director |
SELL
Open market or private sale
|
Direct |
2,045
-8.55%
|
$12,270
$6.62 P/Share
|
|
May 14
2021
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+18.97%
|
-
|
|
May 14
2021
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+12.6%
|
-
|
|
May 14
2021
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+1.0%
|
-
|
|
May 14
2021
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+40.14%
|
-
|
|
May 14
2021
|
Lota S. Zoth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+26.66%
|
-
|
|
May 14
2021
|
Ann Calby Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+25.62%
|
-
|
|
Apr 21
2021
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
26,583
-1.52%
|
$212,664
$8.56 P/Share
|
|
Apr 21
2021
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+2.5%
|
$45,000
$2.4 P/Share
|
|
Apr 21
2021
|
Peter Kies CFO |
SELL
Open market or private sale
|
Direct |
10,000
-5.86%
|
$80,000
$8.52 P/Share
|
|
Apr 16
2021
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.73%
|
$16,000
$8.75 P/Share
|
|
Apr 16
2021
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.59%
|
$6,000
$3.56 P/Share
|